How Medibank Private Ltd could slash costs and lift profits

Incoming CEO Craig Drummond looks to have his eye on the ball when he takes over Medibank Private Ltd (ASX:MPL) in July.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Medibank Private Ltd's (ASX: MPL) new CEO, Craig Drummond, has shared his thoughts on the company's direction with Fairfax media. His comments should reassure investors that he has the company's (and shareholders') best interests at heart:

  • One of his first tasks is to bring government, insurers, and healthcare providers together to get a more sustainable business model
  • Healthcare insurance/expenditure is consistently growing significantly faster than inflation, which means it is ultimately unsustainable according to the new CEO
  • Would not comment on Medibank's dual-brand strategy, but says there needs to be a 'continued focus for us all on improving our customer value proposition'

Mr Drummond certainly has his work cut out for him, as Medibank's premiums have risen consistently at around 6% per annum, prompting a number of customers to downgrade their insurance, change providers, or cancel their coverage entirely.

Outgoing CEO George Savvides has been able to significantly improve Medibank's profitability through reducing costs by renegotiating deals with healthcare providers, although he claims there is still significant room for improvement. Medibank also recently published a report identifying $1 billion in savings that could be made within the healthcare system, an agenda Mr Drummond looks set to continue.

In addition to the struggle of dwindling customer numbers and rising costs, Medibank also faces external problems, in the form of competitors like Bupa and NIB Holdings Limited (ASX: NHF). Bupa in particular is the second largest insurer in Australia and is nipping at Medibank's heels.

While this might be enough to turn the stomach of potential investors, readers should also bear in mind that Medibank is a market-leading business, has a strong brand presence, the market power to receive better terms from suppliers, and a capable incoming CEO.

Although the company is not cheap, I don't see any compelling reason to sell and continue to believe the business is a 'Hold' today.

Motley Fool contributor Sean O'Neill has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »